Estimating the risk for secondary cancer following targeted alpha therapy with astatine-211 intraperitoneal radioimmunotherapy.

Details

Language :

English

ISSN :

01615505

Volume :

63

Issue :

10

Database :

Complementary Index

Journal :

Journal of Nuclear Medicine

Publication Type :

Academic Journal

Accession number :

159850596

Full Text :

https://doi.org/10.2967/jnumed.121.263349